International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-2 doi: 10.5281/zenodo.7791675
Case Report
Warthintumor in a young non-smoker female diagnosed on Fine Needle Aspiration Cytology – A rare Case Report
 ,
 ,
 ,
Published
April 1, 2023
Abstract
Warthintumor is the second most common benign tumor occurring in the Salivary Glands following Pleomorphic Adenoma. It gets its name from the American Pathologist – ‘Aldred Scott Warthin,’ who described it in 1929. The tumor commonly affects males with incidence peaking around 6th-7th decade. Smoking is a well-established etiological agent of Warthin tumor. We hereby describe a case of a young non-smoker female who presented with a painless swelling in the infra-auricular region. Fine needle aspiration cytology of the swelling revealed oncocytes arranged in sheets, clusters and scattered singly. Cells had abundant amount of granular cytoplasm with eccentric nuclei. Background was composed of lymphocytes and granular debris. Diagnosis was rendered as - ‘Milan Category IV-A’ – NEOPLASM: BENIGN suggestive of Warthin tumor according to The Milan System for Reporting Salivary Gland Cytopathology. The patient underwent superficial parotidectomy and the specimen of the same was received in the histopathology department. Gross examination revealed that the tumor was ovoid and well circumscribed with cut section showing solid-cystic areas. Microscopy revealed that the tumor comprised of both epithelial and lymphocytic component with epithelium thrown into papillary folds. The epithelium was oncocytic with foci showing squamous metaplasia. The final diagnosis was confirmed as ‘Warthin tumor.’ A young non-smoker female presenting as Warthin tumor is a rare entity. The recent changing trends in mean age and decrease in gender predilection for men not only needs careful and comprehensive evaluation of the patients by the clinicians but also more research work regarding the pathogenesis needs to be carried out
Recommended Articles
Loading Image...
Volume-4, Issue-2
Citations
1916 Views
134 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved